Administration, Intranasal

"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Delivery of medications through the nasal mucosa.

Descriptor ID	D000281
MeSH Number(s)	E02.319.267.120.655.500
Concept/Terms	Administration, Intranasal Administration, Intranasal Intranasal Drug Administration Drug Administration, Intranasal Intranasal Administration Administrations, Intranasal Intranasal Administrations Administration, Intranasal Drug Administrations, Intranasal Drug Drug Administrations, Intranasal Intranasal Drug Administrations Administration, Nasal Administrations, Nasal Nasal Administration Nasal Administrations

Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Topical [E02.319.267.120]
Administration, Mucosal [E02.319.267.120.655]
Administration, Intranasal [E02.319.267.120.655.500]

Below are MeSH descriptors whose meaning is related to "Administration, Intranasal".

Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.

Bar chart showing 87 publications over 27 distinct years, with a maximum of 8 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	2	2
1998	0	1	1
2000	0	1	1
2001	0	1	1
2003	0	4	4
2004	1	0	1
2005	0	2	2
2006	0	4	4
2007	0	4	4
2008	0	6	6
2009	0	3	3
2010	0	3	3
2011	1	2	3
2012	0	2	2
2013	0	3	3
2014	1	3	4
2015	0	3	3
2016	0	2	2
2017	2	6	8
2018	0	7	7
2019	0	2	2
2020	0	5	5
2021	1	6	7
2022	0	3	3
2023	0	2	2
2024	1	2	3
2025	0	1	1

Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.

Humphrey TJL, Qian W, Chen-Xu M, Dowling F, Gatley K, Adhikari R, Hensman T, Stockley L, Bassi A, Bathla N, Dasgupta I, Dosanjh DPS, Jellings? M, S?rensen P, Jensen ML, Callesen AW, Bradley JR, Jha V, Sommer MOA, Hiemstra TF, Smith RM. Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial. BMC Infect Dis. 2025 Feb 11; 25(1):204.

View in: PubMed
Tepper SJ, Albrecht D, Ailani J, Kirby L, Strom S, Rapoport AM. Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study. CNS Drugs. 2024 12; 38(12):1017-1027.

View in: PubMed
Fern?ndez-Rodr?guez D, Cho J, Chisari E, Citardi MJ, Parvizi J. Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial. Sci Rep. 2024 07 20; 14(1):16739.

View in: PubMed
Vera R, Hong N, Jiang B, Liang G, Eckenhoff MF, Kincaid HJ, Browne V, Chellaraj V, Gisewhite D, Greenberg M, Ranjan S, Zhu G, Wei H. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice. J Alzheimers Dis. 2024; 98(2):549-562.

View in: PubMed
Quezada M, Ponce C, Berr?os-C?rcamo P, Santapau D, Gallardo J, De Gregorio C, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, Israel Y, Andr?s-Herrera P, Hip?lito L, Ezquer F. Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence. CNS Neurosci Ther. 2024 04; 30(4):e14517.

View in: PubMed
Rao AV, Stowens JC. Intranasal Fentanyl: Assessing Analgesic Modalities in the Pediatric Emergency Department. Pediatr Emerg Care. 2023 02 01; 39(2):e59.

View in: PubMed
Misra SN, Sperling MR, Rao VR, Peters JM, Davis C, Carrazana E, Rabinowicz AL. Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters. Epilepsia. 2022 10; 63(10):2684-2693.

View in: PubMed
Cascino GD, Tarquinio D, Wheless JW, Hogan RE, Sperling MR, Desai J, Vazquez B, Samara E, Misra SN, Carrazana E, Rabinowicz AL. Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4?h for acute treatment of seizure clusters: A population analysis. Epilepsia. 2022 07; 63(7):1714-1723.

View in: PubMed
Sperling MR, Wheless JW, Hogan RE, Dlugos D, Cascino GD, Liow K, Rabinowicz AL, Carrazana E. Use of second doses of Valtoco? (diazepam nasal spray) across 24?hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study. Epilepsia. 2022 04; 63(4):836-843.

View in: PubMed
Jain S, Durugkar S, Saha P, Gokhale SB, Naidu VGM, Sharma P. Effects of intranasal azithromycin on features of cigarette smoke-induced lung inflammation. Eur J Pharmacol. 2022 Jan 15; 915:174467.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement